Literature DB >> 23966803

Resolution of exudative retinal detachment and regression of retinal macrocyst post-laser in Coats disease.

Yusoff Munira1, Embong Zunaina, Yaakub Azhany.   

Abstract

A 15-year-old boy presented with painless progressive blurring of vision in the right eye for 1 year in duration. His visual acuity in the right eye was hand movement. The right fundus showed presence of extensive subretinal exudates at the posterior pole and a retinal macrocyst at the temporal periphery. It was associated with exudative retinal detachment at the inferior periphery of the retina. Fundus angiography revealed telangiectatic retinal vessels at the superotemporal retina. Based on clinical and angiographic findings, a diagnosis of Coats disease was made. He was treated with retinal laser photocoagulation. There was resolution of the exudative retinal detachment, reduction of subretinal exudates, and regression of the retinal macrocyst with improvement of visual acuity to 1/60 post-laser therapy.

Entities:  

Keywords:  Coats disease; exudative retinal detachment; laser; retinal macrocyst

Year:  2013        PMID: 23966803      PMCID: PMC3743637          DOI: 10.2147/IMCRJ.S47769

Source DB:  PubMed          Journal:  Int Med Case Rep J        ISSN: 1179-142X


Introduction

Coats disease is a rare idiopathic retinal vascular disease characterized by abnormal telangiectatic vessels with progressive deposition of intraretinal or subretinal exudates. It usually affects boys in their first to second decade of life and less commonly presents in adulthood.1 It is unilateral in 90% of cases. Coats disease normally progresses slowly and results in a gradual loss of vision.2 Coats disease is classified into stage 1 (telangiectasia only), stage 2 (telangiectasia and exudation; 2A, extrafoveal exudation; 2B, foveal exudation), stage 3 (exudative retinal detachment; 3A, subtotal; 3B, total), stage 4 (total retinal detachment and secondary glaucoma), and stage 5 (advanced end-stage disease).3 Treatment is aimed at obliterating the abnormal vessels by either laser photocoagulation2,3 or cryotherapy,3 while vitrectomy3,4 is generally indicated when retinal detachment occurs.

Case report

A 15-year-old boy presented with painless progressive blurring of vision in the right eye for one year in duration. It was not associated with floaters or fashes of light and there was no history of trauma. He was born full term via spontaneous vaginal delivery and had no past ocular history or medical illness. Visual acuity in his right eye was hand movement and his left visual acuity was 6/6. Anterior segment examination was normal with a normal pupillary reaction in both eyes. The right fundus showed the presence of extensive subretinal exudates at the posterior pole (macular area) extending to the superotemporal arcade (Figure 1). There was also the presence of a retinal macrocyst at the temporal periphery of the retina (Figure 2A). This was associated with exudative retinal detachment at the inferior periphery of the retina with no foveal involvement. There was the presence of telangiectatic retinal vessels at the superotemporal retina. The left fundus was normal with an absence of subretinal exudates or any abnormal retinal vessels. B-scan ultrasound showed the presence of inferior retinal detachment with no mass lesion or calcification. Fundus angiography revealed telangiectatic retinal vessels at the superotemporal retina.
Figure 1

Fundus findings at presentation show extensive subretinal exudates at posterior pole (C) and superotemporal arcade (D). (A) surrounding the optic disc, (B) inferior arcade.

Figure 2

Fundus finding shows retinal macrocyst at temporal periphery of retina (arrow) at presentation (A) and regression of the retinal macrocyst (arrow) at 2 years post-retinal laser photocoagulation (B).

Based on clinical and angiographic findings, a diagnosis of Coats disease in the right eye was made. The patient was classified as having Coats disease stage 3A based on the presence of exudative retinal detachment with no foveal involvement. He was treated with retinal laser photocoagulation at the area of telangiectatic vessels aiming to cause regression of these vessels. The laser therapy was given in four sessions within 3 months. At 3-month follow-up after initial presentation, the exudative retinal detachment was resolved with minimal reduction of subretinal exudates. Review at 14 months post-retinal laser photocoagulation showed a reduction of the subretinal exudates at the posterior pole (Figure 3). There was regression of the size of the retinal macrocyst with reduction of subretinal exudates surrounding the retinal macrocyst at 2 years post-retinal laser photocoagulation (Figure 2B). His right visual acuity was improved to 1/60, with no further improvement due to persistent dense and calcified subretinal exudates at the fovea.
Figure 3

Fundus finding at 14 months post-retinal laser photocoagulation at posterior pole (A) and optic disc (B).

Discussion

The hallmark lesion of Coats disease is retinal telangiectasia and subretinal exudates, as seen in this case. The pathologic process that causes the exudation is increased permeability of telangiectatic vessels, causing leakage of lipoprotein into the retina and subsequently retinal edema.5,6 Expression of vascular endothelial growth factor is observed in macrophages infiltrating the subretinal space. Immunoreactivity for vascular endothelial growth factor receptor-2 was detected in endothelial cells lining the abnormal retinal vessels.7 The exudation seen is not associated with any sign of vitreoretinal traction. Exudates may also disrupt the underlying retina causing exudative retinal detachment.5 Other complications of Coats disease include intraretinal macrocyst.8 Retinal macrocyst appears to correlate with the presence of retinal detachment.3,8 Telangiectatic vessels found in Coats disease are localized to a focal area on the retina. These telangiectasias may also involve a large area of the retina. Macular exudation may be caused by macular telangiectasia, peripheral retinal telangiectasia, or both.9 Exudates that involve the macular area definitely cause poor vision,10 and if longstanding, may result in macular scarring, cystoid macular edema, or subfoveal fibrosis.3 Treatment by laser photocoagulation is aimed at obliterating the abnormal telangiectatic blood vessels. Cryotherapy is indicated if the abnormal vessels are in the periphery or a large area of exudation is present beneath the telangiectatic vessels.11 Treatment of peripheral telangiectatic vessels resulted in resolution of the exudation both in the retinal periphery and at the macula. Intravitreal bevacizumab plus thermal ablation showed resolution of disease in most severe cases.12 Complications of abnormal retinal vessels such as vitreous hemorrhage or subhyaloid hemorrhage may necessitate vitrectomy to clear the bleeding. Enucleation is indicated in cases with total retinal detachment associated with glaucoma in order to relieve severe ocular pain.3 In this case report, the patient was treated with retinal laser photocoagulation which resulted in resolution of exudative retinal detachment, reduction of subretinal exudates, and regression of retinal macrocyst. However, the visual prognosis is poor due to dense and calcified foveal exudation.

Conclusion

Even though the outcomes are not so promising, treatment, especially for the localized form of Coats disease, is highly recommended because the prognosis without treatment is almost invariably poor.
  12 in total

1.  [Long-term prognosis of 5 cases with stage 3A Coats disease after vitrectomy].

Authors:  Hiroshi Nakashima; Kazuyuki Emi; Tatsuhiko Sato; Chiharu Iwahashi-Shima; Hajime Bando; Toshihide Ikeda
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2012-06

2.  Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.

Authors:  Shalini Kaul; Mahesh Uparkar; Kruti Mody; Jaydeep Walinjkar; Mihir Kothari; S Natarajan
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

3.  Treatment of Coats' disease with intravitreal bevacizumab.

Authors:  Robin Ray; David E Barañano; G Baker Hubbard
Journal:  Br J Ophthalmol       Date:  2012-12-25       Impact factor: 4.638

4.  Coats disease in a Nigerian man with a favorable structural outcome following retinal laser photocoagulation.

Authors:  Abdulraheem O Mahmoud; Olubayo Kolawole; Tayo Ibrahim; Lateefat Olokoba
Journal:  Ann Afr Med       Date:  2013 Jan-Mar

5.  Coat's disease: clinical, angiographic, histopathological findings and clinical management.

Authors:  A Tarkkanen; L Laatikainen
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

6.  Classification and management of Coats disease: the 2000 Proctor Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci; J Cater
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  Expression of vascular endothelial growth factor in eyes with Coats' disease.

Authors:  Satoru Kase; Narsing A Rao; Hiroshi Yoshikawa; Junichi Fukuhara; Kousuke Noda; Atsuhiro Kanda; Susumu Ishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

9.  Over 10 years follow-up of Coats' disease in adulthood.

Authors:  Tatsuro Otani; Kanako Yasuda; Naoko Aizawa; Fumiaki Sakai; Toru Nakazawa; Masahiko Shimura
Journal:  Clin Ophthalmol       Date:  2011-12-08

10.  Transscleral diode photocoagulation of large retinal and choroidal vascular lesions.

Authors:  Yun Feng; Zhizhong Ma
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.